NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: GOVERNMENT OWNED INVENTIONS AVAILABLE FOR LICENSE: COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELL-BASED VACCINES WITH ENHANCED EFFICACY

WASHINGTON, June 25 -- National Institutes of Health has issued a notice called: Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy.

The notice was published in the Federal Register on June 25 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.

Summary: The National Cancer Institute (NCI) is seeking research co-development partners and/or licensees for NCI's compositions and methods to enhance the efficacy of dendritic cell (DC)-based cancer vaccines.

For more information, contact Inquiries related to this license opportunity should be directed to: Diptadip Dattaroy, Ph.D, Technology Transfer Manager...